In a report published Friday, Oppenheimer analyst Steve Manaker reiterated an Outperform rating on Physicians Realty Trust DOC, and raised the price target from $16.75 to $18.00.
In the report, Oppenheimer noted, “We maintain our Outperform rating and raise our price target to $18 despite lowering our 2015 FFO estimate. Our new price target implies a 13.8% total return, including the 5.8% dividend yield. DOC closed $105 million of acquisitions in 4Q14 and is starting 2015 with $206 million of acquisitions near closing. In order to finance the pipeline, DOC announced the sale of 15 million shares. Previously, we assumed a similar-sized offering but at the end of 2Q15. This change is lowering our 2015 FFO estimate to $1.00 from $1.03, but our 4Q15 estimate remains the same—this is our stable quarterly run-rate FFO est. for DOC assuming $450 million of acquisitions done in the first nine months of 2015.”
Physicians Realty Trust closed on Thursday at $16.64.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in